Skip to main content
Top

Supportive Care in Cancer

Issue 4/2007

Content (14 Articles)

Supportive Care International

A survey of National Cancer Institute-designated comprehensive cancer centers’ oral health supportive care practices and resources in the USA

Joel B. Epstein, Ira R. Parker, Matthew S. Epstein, Anurag Gupta, Susan Kutis, Daniela M. Witkowski

Review Article

What is new in neuropathic pain?

Mellar P. Davis

Review Article

Review of patterns of practice and patients’ preferences in the treatment of bone metastases with palliative radiotherapy

Nicole M. E. Bradley, Janice Husted, Michael Sai Lai Sey, Amna F. Husain, Emily Sinclair, Kristin Harris, Edward Chow

Original Article

The prognostic association of health-related quality of life scores with survival in breast cancer

Digant Gupta, Joel Granick, James F. Grutsch, Christopher G. Lis

Open Access Original Article

Temperament as a predictor of internalising and externalising problems in adolescent children of parents diagnosed with cancer

Annemieke Visser, Gea A. Huizinga, Harald J. Hoekstra, Winette T. A. van der Graaf, Josette E. H. M. Hoekstra-Weebers

Original Article

Life after cancer: couples’ and partners’ psychological adjustment and supportive care needs

K. Hodgkinson, P. Butow, G. E. Hunt, R. Wyse, K. M. Hobbs, G. Wain

Short Communication

Is there a ceiling effect of transdermal buprenorphine? Preliminary data in cancer patients

Sebastiano Mercadante, Patrizia Ferrera, Patrizia Villari

Short Communication

Successful management of infusion reaction accompanying the start of cetuximab therapy

Bohuslav Melichar, Jaroslav Cerman Jr., Eva Malířová

Short Communication

Pain flare in patients with bone metastases after palliative radiotherapy—a nested randomized control trial

D. Andrew Loblaw, Jackson SY Wu, Peter Kirkbride, Tony Panzarella, Katherine Smith, Julie Aslanidis, Padraig Warde

Forthcoming Meetings

Forthcoming Meetings

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine